Abstract
Fabry disease (FD) is a progressive, X-linked inherited disorder of glycosphingolipid metabolism due to deficient or absent lysosomal α-galactosidase A activity. FD is pan-ethnic and the reported annual incidence of 1 in 100,000 may underestimate the true prevalence of the disease. Classically affected hemizygous males, with no residual α-galactosidase A activity may display all the characteristic neurological (pain), cutaneous (angiokeratoma), renal (proteinuria, kidney failure), cardiovascular (cardiomyopathy, arrhythmia), cochleo-vestibular and cerebrovascular (transient ischemic attacks, strokes) signs of the disease while heterozygous females have symptoms ranging from very mild to severe. Deficient…
Citation impact
1,175
total citations
- FWCI
- 13.93
- Percentile
- 100%
- References
- 438
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Globotriaosylceramide
- Angiokeratoma
- Enzyme replacement therapy
- Fabry disease
- Medicine
- Disease
- Genetic counseling
- Genetic disorder
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.